| Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers MJ Curtis, S Alexander, G Cirino, JR Docherty, CH George, MA Giembycz, ... British journal of pharmacology 175 (7), 987-993, 2018 | 1269 | 2018 |
| Experimental design and analysis and their reporting: new guidance for publication in BJP MJ Curtis, RA Bond, D Spina, A Ahluwalia, SPA Alexander, MA Giembycz, ... British journal of pharmacology 172 (14), 3461, 2015 | 1118 | 2015 |
| TNF receptor subtype signalling: differences and cellular consequences DJ MacEwan Cellular signalling 14 (6), 477-492, 2002 | 852 | 2002 |
| TNF ligands and receptors–a matter of life and death DJ MacEwan British journal of pharmacology 135 (4), 855, 2002 | 596 | 2002 |
| Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology SPH Alexander, RE Roberts, BRS Broughton, CG Sobey, CH George, ... British journal of pharmacology 175 (3), 407, 2018 | 567 | 2018 |
| The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance SA Rushworth, L Zaitseva, MY Murray, NM Shah, KM Bowles, ... Blood, The Journal of the American Society of Hematology 120 (26), 5188-5198, 2012 | 315 | 2012 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 308 | 2017 |
| TNFR1-induced NF-κB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells Z Zhou, MC Connell, DJ MacEwan Cellular signalling 19 (6), 1238-1248, 2007 | 276 | 2007 |
| Lipopolysaccharide-induced expression of NAD (P) H: quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes SA Rushworth, DJ MacEwan, MA O'Connell The Journal of Immunology 181 (10), 6730-6737, 2008 | 247 | 2008 |
| The concise guide to PHARMACOLOGY 2015/16: Overview SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ... British journal of pharmacology 172 (24), 5729-5743, 2015 | 241 | 2015 |
| Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons AA Coutts, S Anavi-Goffer, RA Ross, DJ MacEwan, K Mackie, RG Pertwee, ... Journal of Neuroscience 21 (7), 2425-2433, 2001 | 221 | 2001 |
| TNF-α receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones J Pollock, SM McFarlane, MC Connell, U Zehavi, P Vandenabeele, ... Neuropharmacology 42 (1), 93-106, 2002 | 210 | 2002 |
| Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception RA Ross, AA Coutts, SM McFarlane, S Anavi-Goffer, AJ Irving, ... Neuropharmacology 40 (2), 221-232, 2001 | 210 | 2001 |
| The concise guide to pharmacology 2019/20: Catalytic receptors SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British journal of pharmacology 176, S247-S296, 2019 | 180 | 2019 |
| HO-1 underlies resistance of AML cells to TNF-induced apoptosis SA Rushworth, DJ MacEwan Blood, The Journal of the American Society of Hematology 111 (7), 3793-3801, 2008 | 176 | 2008 |
| New perspectives, opportunities, and challenges in exploring the human protein kinome LJ Wilson, A Linley, DE Hammond, FE Hood, JM Coulson, DJ MacEwan, ... Cancer research 78 (1), 15-29, 2018 | 166 | 2018 |
| The concise guide to pharmacology 2021/22: Catalytic receptors SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British Journal of Pharmacology 178, S264-S312, 2021 | 158 | 2021 |
| Identification of Bruton’s tyrosine kinase as a therapeutic target in acute myeloid leukemia SA Rushworth, MY Murray, L Zaitseva, KM Bowles, DJ MacEwan Blood, The Journal of the American Society of Hematology 123 (8), 1229-1238, 2014 | 140 | 2014 |
| Tumor necrosis factor-α–induced activation of RhoA in airway smooth muscle cells: Role in the Ca2+ sensitization of myosin light Chain20 phosphorylation I Hunter, HJ Cobban, P Vandenabeele, DJ MacEwan, GF Nixon Molecular pharmacology 63 (3), 714-721, 2003 | 131 | 2003 |
| BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB SA Rushworth, KM Bowles, LN Barrera, MY Murray, L Zaitseva, ... Cellular signalling 25 (1), 106-112, 2013 | 128 | 2013 |
